Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use-Reference-Cited by-同舟云学术

Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use

Author:

Taleb Nadine¹²,Haidar Ahmad³⁴,Messier Virginie¹,Gingras Véronique¹⁵,Legault Laurent⁶,Rabasa-Lhoret Rémi¹⁷⁵

Affiliation:

1. Metabolic diseases unit, Institut de recherches cliniques de Montréal; Montréal Québec Canada

2. Department of Biomedical Sciences, Faculty of Medicine, Édouard-Montpetit; Université de Montréal; Montréal Québec Canada

3. Department of Biomedical Engineering, Faculty of Medicine; McGill University; Montréal Québec Canada

4. Division of Endocrinology, Department of Medicine, Faculty of Medicine; McGill University; Montréal Québec Canada

5. Nutrition Department, Faculty of Medicine; Université de Montréal; Montréal Québec Canada

6. Montreal Children's Hospital; Department of Pediatrics, McGill University Health Centre; Montréal Québec Canada

7. Montreal Diabetes Research Center; Montréal Québec Canada

Funder

NIH

J-A DeSéve Chair

Boehringer Ingelheim

Novo Nordisk

Roche

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference132 articles.

1. Purification and crystallization of glucagon;Staub;J Biol Chem,1955

4. The physiology of glucagon;Taborsky;J Diabetes Sci Technol,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献